This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



  • Nanotech Method Detects Respiratory Virus
    In what may be one of the first medical uses of nanotechnology, a chemist and a doctor who specializes in infectious childhood diseases have joined forces to create an early detection method for a respiratory virus that is the most common cause of hospitalization among ...More
    June 10, 2005 Posted in News
  • Watch and Wait: A Shift in Approach to Kids' Ear Infections
    The most frequent reason pediatricians prescribe antibiotics to young children is for an ear infection (acute otitis media). With increased concerns about high rates of antibiotic use and resistance, recent guidelines suggest consideration of "watchful waiting" for some ear ...More
    June 6, 2005 Posted in News
  • Nabi Biopharmaceuticals Initiates S. Epidermidis Vaccine Phase I Study
    ROCKVILLE, Md. -- Nabi Biopharmaceuticals announced today the initiation of the first human clinical study of its vaccine being developed to prevent Staphylococcus epidermidis infections in at-risk patients.  At-risk patients include neonates, patients with indwelling ...More
    May 26, 2005 Posted in News
  • B. Braun to Offer FDA-Approved Ceftriaxone in the Duplex Drug-Delivery System
    BETHLEHEM, Pa. -- B. Braun Medical Inc. today announced that it received FDA approval for CefTRIaxONE in the DUPLEX® Drug Delivery System.  The availability of CefTRIaxONE, a standard intravenous antibiotic preparation, helps clinicians comply with Joint Commission on ...More
    May 10, 2005 Posted in News
  • Inhibitex Reports Favorable Results From Aurexis Phase II Trial for the Treatment of Staph Bloodstream Infections
    ATLANTA -- Inhibitex, Inc.  today reported top-line findings from its Phase II clinical trial of Aurexis for the adjunctive treatment of serious, life threatening Staphylococcus aureus (S. aureus) bloodstream infections in combination with antibiotics. Favorable ...More
    May 9, 2005 Posted in News
  • Two Studies Document Rise of Superbugs in the Environment
    As science gets wiser, so do the bugs. The rates of drug-resistant bacteria infecting patients in the community and in the hospital have been increasing steadily in recent years, according to two new studies in the June, 2005 15 issue of Clinical Infectious Diseases. Drug ...More
    May 9, 2005 Posted in News
  • New Data Shows Use of Antibiotics to Treat Ear Infections is Falling
    The proportion of children who were given an antibiotic specifically to treat otitis media, a commonly diagnosed ear condition, declined from 14.4 percent in 1996 to 11.5 percent in 2001, according to new data from HHS’ Agency for Healthcare Research and Quality (AHRQ). The ...More
    May 2, 2005 Posted in News
  • Collaboratives Demonstrate Gains in Fighting Surgical Infections
    Collaboratives Demonstrate Gains in Fighting Surgical Infections By Kelly M. Pyrek In the two years since a national campaign was launched to help fight surgical site infections (SSIs), several hundred hospitals are successfully implementing clinical processes to prevent ...More
    May 1, 2005 Posted in Articles
  • The Basics of Pressure Ulcers
    Essentials of Wound and Burn CareBy John Roark Burns, punctures, cuts, surgical incisions, pressure sores and diabetic ulcers are all wounds that can easily become infected. Preventative measures must be taken to avoid this danger.Simply put, an infected wound contains a ...More
    April 1, 2005 Posted in Articles
  • Study Finds Duration and Severity of Bronchitis Reduced by Unique Cold Medicine
    SALT LAKE CITY -- Cases of bronchitis may be on the rise as cough and cold season has reached its peak.  But this year consumers and physicians have an effective alternative to current over-the-counter medications offering only symptomatic relief, as well as ...More
    February 22, 2005 Posted in News